A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

Completed · Phase 2 · Has a placebo group

Conditions studied: Narcolepsy

In brief

This is a study to evaluate the safety and effectiveness of ADX-N05 compared to placebo in the treatment of excessive daytime sleepiness in adults with narcolepsy.

Key facts

Study ID
NCT01485770
Run by
Jazz Pharmaceuticals
People needed
33
Starts
2011-12-01
Expected to finish
2012-05-01
Last updated by the study team
2021-07-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.